Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 7/20 | 1.00 |
| ▸ | PPARD | Q03181 | 6/20 | 1.00 |
| ▸ | PPARA | Q07869 | 6/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | F7 | P08709 | 5/20 | 1.00 |
| ▸ | F3 | P13726 | 5/20 | 1.00 |
| ▸ | FABP4 | P15090 | 4/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 1.00 |
| ▸ | FFAR1 | O14842 | 3/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 3/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 3/20 | 1.00 |
| ▸ | NR4A2 | P43354 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | AKR1C3 | P42330 | 2/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 1.00 |
| ▸ | DUSP3 | P51452 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16685715 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1F7 | |
| SCHEMBL15880317 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1F7 | |
| Linoleic Acid SCHEMBL20856202 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1F7 | |
| SCHEMBL22498259 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1F7 | |
| SCHEMBL22498256 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1F7 | |
| Arachidic Acid SCHEMBL20528087 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1F7 | |
| Linoleic Acid SCHEMBL25294178 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1F7 | |
| SCHEMBL22498258 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1F7 | |
| Dihomo-Gamma-Linolenic Acid SCHEMBL20656585 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1F7 | |
| SCHEMBL21411004 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1F7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8426625-B2 | Bis-platinum complexes with antitumor activity | CELL THERAPEUTICS, INC. (US) | 2013-04-23 | — | — | US | claimed |
| US-20100292322-A1 | Bis-Platinum Complexes With Antitumor Activity | CELL THERAPEUTICS, INC. | 2010-11-18 | — | — | US | claimed |
| EP-1968991-A1 | BIS-PLATINUM COMPLEXES WITH ANTITUMOR ACTIVITY | Sede Secondaria Della Cell Therapeutics, Inc. (IT) | 2008-09-17 | — | — | EP | claimed |
| WO-2007071415-A1 | BIS-PLATINUM COMPLEXES WITH ANTITUMOR ACTIVITY | CELL THERAPEUTICS, INC. - SEDE SECONDARIA (IT) | 2007-06-28 | — | — | WO | claimed |
| US-20260139250-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER BY TARGETING ONCOGENIC TRANSFER RNAS | THE CHILDRENS MEDICAL CENTER CORP (US) | 2026-05-21 | — | — | US | disclosed |
| US-12590320-B2 | Cellular models of and therapies for ocular diseases | REFLECTION BIOTECHNOLOGIES LIMITED (HK) | 2026-03-31 | — | — | US | disclosed |
| US-20250258146-A1 | QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP | HUMAN METABOLOMICS INSTITUTE INC. (CN) | 2025-08-14 | — | — | US | disclosed |
| EP-4583720-A1 | COMPOSITIONS AND METHODS FOR PRODUCING MEAT-LIKE AROMAS | Nourish Ingredients Pty Ltd (AU) | 2025-07-16 | — | — | EP | disclosed |
| EP-4583721-A1 | COMPOSITIONS AND METHODS FOR PRODUCING MEAT-LIKE AROMAS | Nourish Ingredients Pty Ltd (AU) | 2025-07-16 | — | — | EP | disclosed |
| EP-4583719-A1 | COMPOSITIONS AND METHODS FOR PRODUCING AROMAS | Nourish Ingredients Pty Ltd (AU) | 2025-07-16 | — | — | EP | disclosed |
| EP-4551702-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER BY TARGETING ONCOGENIC TRANSFER RNAS | The Children's Medical Center Corporation (US) | 2025-05-14 | — | — | EP | disclosed |
| WO-2025085964-A1 | SHORT CHAIN LIPIDS | Nourish Ingredients Pty Ltd (AU) | 2025-05-01 | — | — | WO | disclosed |
| US-20100330160-A1 | Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6 | SANOFI PASTEUR (FR) | 2010-12-30 | — | — | US | disclosed |
| US-20100292322-A1 | Bis-Platinum Complexes With Antitumor Activity | CELL THERAPEUTICS, INC. | 2010-11-18 | — | — | US | disclosed |
| US-20100291192-A1 | Detoxification method for lipopolysaccharide (LPS) or lipid A of gram-negative bacteria | SANOFI PASTEUR (FR) | 2010-11-18 | — | — | US | disclosed |
| EP-1968991-A1 | BIS-PLATINUM COMPLEXES WITH ANTITUMOR ACTIVITY | Sede Secondaria Della Cell Therapeutics, Inc. (IT) | 2008-09-17 | — | — | EP | disclosed |
| EP-1484445-B1 | Use of carboxylic perfluoropolyethers for the oleo-repellent paper sizing | SOLVAY SOLEXIS SPA (IT) | 2007-07-11 | — | — | EP | disclosed |
| WO-2007071415-A1 | BIS-PLATINUM COMPLEXES WITH ANTITUMOR ACTIVITY | CELL THERAPEUTICS, INC. - SEDE SECONDARIA (IT) | 2007-06-28 | — | — | WO | disclosed |
| EP-1489124-A1 | (Per)fluoropolyether carboxylic acids and use thereof for the oleo-repellent paper sizing | Solvay Solexis S.p.A. (IT) | 2004-12-22 | — | — | EP | disclosed |
| EP-1484445-A1 | Use of carboxylic perfluoropolyethers for the oleo-repellent paper sizing | Solvay Solexis S.p.A. (IT) | 2004-12-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100292322-A1 | Bis-Platinum Complexes With Antitumor Activity | IDH3B, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, IDH1 | PPARG 1538/4885PPARD 1665/4885PPARA 1311/4885 |
| US-20260139250-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER BY TARGETING ONCOGENIC TRANSFER RNAS | TRDMT1, METTL16, TRMT1 | PPARG 3490/4885PPARD 4218/4885PPARA 3987/4885 |
| US-20100330160-A1 | Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6 | PHOSPHO1, FUT6, MAGT1 | PPARG 4163/4885PPARD 4405/4885PPARA 3152/4885 |
| US-12590320-B2 | Cellular models of and therapies for ocular diseases | ALDH1A2, NR2E3, RBP4 | PPARG 1904/4885PPARD 1504/4885PPARA 3583/4885 |
| US-20100291192-A1 | Detoxification method for lipopolysaccharide (LPS) or lipid A of gram-negative bacteria | LIPA, MGLL, LIPC | PPARG 158/4885PPARD 617/4885PPARA 101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.